Silicon Labs Reports Fourth Quarter and Full Year 2022 Results
Silicon Labs (NASDAQ: SLAB) reported a strong fourth quarter for 2022, achieving revenue of $257 million, a 23% increase year-on-year. The company has doubled its organic revenue to over $1 billion annually in two years, supported by substantial design wins, which rose by 120%. The Industrial & Commercial segment saw a 36% revenue growth, while Home & Life increased by 8%. The gross margin was 61%, and non-GAAP diluted earnings per share reached $1.31. Looking ahead, Silicon Labs expects first-quarter 2023 revenue between $242 to $252 million and maintains confidence in its IoT leadership amid economic uncertainty.
- Revenue of $257 million in Q4 2022, up 23% year-on-year.
- Doubled organic revenue to over $1 billion in two years.
- Design wins increased by 120%, indicating strong market demand.
- Industrial & Commercial revenue rose 36% year-on-year.
- Non-GAAP diluted EPS of $1.31, reflecting strong profitability.
- GAAP operating income as a percentage of revenue was only 9%.
- GAAP R&D expenses were significant at $87 million.
IoT leader doubles revenue in two years to more than
"We are incredibly proud of our team's execution in doubling our organic revenue in two years to more than
Fourth Quarter Financial Highlights
- Revenue was
, up$257 million 23% year-on-year - Industrial & Commercial revenue for the quarter was
, up$157 million 36% year-on-year - Home & Life revenue for the quarter was
, up$100 million 8% year-on-year - Gross margin of
61% was favorable due to strong product, pricing, and customer mix in the quarter
Results on a GAAP basis:
- GAAP gross margin was
61% - GAAP R&D expenses were
$87 million - GAAP SG&A expenses were
$47 million - GAAP operating income as a percentage of revenue was
9% - GAAP diluted earnings per share were
$0.76
Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:
- Non-GAAP gross margin was
61% - Non-GAAP R&D expenses were
$70 million - Non-GAAP SG&A expenses were
$39 million - Non-GAAP operating income as a percentage of revenue was
19% - Non-GAAP diluted earnings per share were
$1.31
Business Highlights
The Connectivity Standards Alliance (CSA) announced the release of Matter 1.0, the application layer protocol developed specifically to address device interoperability within the smart home.Silicon Labs is the leading semiconductor company code contributor to Matter, and as of the end of 2022, claims86% of Matter over Thread's industry certifications.Silicon Labs has become a one-stop resource for Matter devices, border routers, and bridges so developers can easily bridge Matter to other IoT development platforms like Wi-Fi, Zigbee, Thread, and Z-Wave while leveraging their experience withSilicon Labs' hardware and tools.Silicon Labs President and CEOMatt Johnson was elected Chair of theSemiconductor Industry Association (SIA) Board of Directors. SIA represents99% of theU.S. semiconductor industry by revenue and nearly two-thirds of non-U.S. chip firms.- Completed the buyback of
of the company's shares in the quarter, resulting in the retirement of 1.6 million shares and bringing the total share repurchase activity since the announcement of the divestiture in$200 million April 2021 to more than , retiring more than$2 billion 25% of the then outstanding shares.
Business Outlook
The company expects first-quarter revenue to be between
On a GAAP basis:
- GAAP gross margin of approximately
63% - GAAP operating expenses of approximately
$139 million - GAAP effective tax rate of approximately
31% - GAAP diluted earnings per share between
to$0.36 $0.46
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
- Non-GAAP gross margin of approximately
63% - Non-GAAP operating expenses of approximately
$111 million - Non-GAAP effective tax rate of approximately
23% - Non-GAAP diluted earnings per share between
to$1.07 $1.17
Earnings Webcast and Conference Call
About
Forward-Looking Statements
This press release contains forward-looking statements based on
Note to editors:
Condensed Consolidated Statements of Operations | ||||||||||
(In thousands, except per share data) | ||||||||||
(Unaudited) | ||||||||||
Three Months Ended | Year Ended | |||||||||
| ||||||||||
Revenues | $ 257,325 | $ 208,680 | $ 1,024,106 | $ 720,860 | ||||||
Cost of revenues | 100,028 | 80,849 | 381,549 | 295,468 | ||||||
Gross profit | 157,297 | 127,831 | 642,557 | 425,392 | ||||||
Operating expenses: | ||||||||||
Research and development | 86,649 | 71,705 | 332,326 | 273,208 | ||||||
Selling, general and administrative | 46,573 | 53,487 | 190,971 | 185,022 | ||||||
Operating expenses | 133,222 | 125,192 | 523,297 | 458,230 | ||||||
Operating income (loss) | 24,075 | 2,639 | 119,260 | (32,838) | ||||||
Other income (expense): | ||||||||||
Interest income and other, net | 4,299 | 2,595 | 13,915 | 5,696 | ||||||
Interest expense | (1,849) | (6,628) | (6,723) | (31,033) | ||||||
Income (loss) from continuing operations before income taxes | 26,525 | (1,394) | 126,452 | (58,175) | ||||||
Provision for income taxes | 1,579 | 884 | 38,450 | 13,427 | ||||||
Equity-method earnings | 415 | 7,791 | 3,400 | 13,728 | ||||||
Income (loss) from continuing operations | 25,361 | 5,513 | 91,402 | (57,874) | ||||||
Income (loss) from discontinued operations, net of income taxes | -- | (8,611) | -- | 2,175,273 | ||||||
Net income (loss) | $ 25,361 | $ (3,098) | $ 91,402 | $ 2,117,399 | ||||||
Basic earnings (loss) per share: | ||||||||||
Continuing operations | $ 0.78 | $ 0.14 | $ 2.61 | $ (1.35) | ||||||
Net income | $ 0.78 | $ (0.08) | $ 2.61 | $ 49.44 | ||||||
Diluted earnings (loss) per share: | ||||||||||
Continuing operations | $ 0.76 | $ 0.13 | $ 2.54 | $ (1.35) | ||||||
Net income | $ 0.76 | $ (0.08) | $ 2.54 | $ 47.78 | ||||||
Weighted-average common shares outstanding: | ||||||||||
Basic | 32,542 | 38,965 | 35,086 | 42,830 | ||||||
Diluted | 33,265 | 41,031 | 36,042 | 44,315 | ||||||
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this document,
The non-GAAP financial measurements do not replace the presentation of
Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures | ||||||||||||||
(In thousands, except per share data) | ||||||||||||||
Three Months Ended | ||||||||||||||
Non-GAAP Income Statement Items | GAAP Measure | GAAP Percent of Revenue | Stock Compensation Expense | Intangible Asset Amortization | Termination Costs & Other | Non-GAAP Measure | Non-GAAP Percent of Revenue | |||||||
Revenues | ||||||||||||||
Gross profit | 157,297 | 61.1 % | $ -- | $ -- | 61.3 % | |||||||||
Research and development | 86,649 | 33.7 % | 9,378 | 6,724 | 873 | 69,674 | 27.1 % | |||||||
Selling, general and administrative | 46,573 | 18.1 % | 7,601 | 19 | (279) | 39,232 | 15.2 % | |||||||
Operating income | 24,075 | 9.4 % | 17,297 | 6,743 | 594 | 48,709 | 18.9 % |
Three Months Ended | |||||||||||||||
Non-GAAP Earnings Per Share | GAAP Measure | Stock Compensation Expense* | Intangible Asset Amortization* | Termination Costs & Other* | Equity-Method Investment Adjustments* | Income Tax Adjustments | Non- GAAP Measure | ||||||||
Net income | |||||||||||||||
Diluted shares outstanding | 33,265 | 33,265 | |||||||||||||
Diluted earnings per share | $ 0.76 | $ 1.31 |
* Represents pre-tax amounts |
Unaudited Forward-Looking Statements Regarding Business Outlook | ||||||
(In millions, except per share data) | ||||||
Business Outlook | Three Months Ending | |||||
GAAP Measure | Non-GAAP Adjustments** | Non-GAAP Measure | ||||
Gross margin | 63 % | 0 % | 63 % | |||
Operating expenses | ||||||
Effective tax rate | 31 % | (8) % | 23 % | |||
Diluted earnings per share - low | ||||||
Diluted earnings per share - high |
** Non-GAAP adjustments include the following estimates: stock compensation expense of |
Condensed Consolidated Balance Sheets | |||
(In thousands, except per share data) | |||
(Unaudited) | |||
2022 |
| ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ 499,915 | ||
Short-term investments | 692,024 | 964,582 | |
Accounts receivable, net | 71,437 | 98,313 | |
Inventories | 100,417 | 49,307 | |
Prepaid expenses and other current assets | 97,570 | 51,748 | |
Total current assets | 1,461,363 | 2,238,573 | |
Property and equipment, net | 152,016 | 146,516 | |
376,389 | 376,389 | ||
Other intangible assets, net | 84,907 | 118,978 | |
Other assets, net | 94,753 | 77,839 | |
Total assets | |||
Liabilities and Stockholders' Equity | |||
Current liabilities: | |||
Accounts payable | $ 89,860 | $ 47,327 | |
Current portion of convertible debt, net | -- | 450,599 | |
Deferred revenue and returns liability | 6,780 | 13,849 | |
Other current liabilities | 89,136 | 157,052 | |
Total current liabilities | 185,776 | 668,827 | |
Convertible debt, net | 529,573 | -- | |
Other non-current liabilities | 49,071 | 77,044 | |
Total liabilities | 764,420 | 745,871 | |
Commitments and contingencies | |||
Stockholders' equity: | |||
Preferred stock – shares issued | -- | -- | |
Common stock – 31,994 and 38,481 shares issued and outstanding at | 3 | 4 | |
Retained earnings | 1,415,693 | 2,214,839 | |
Accumulated other comprehensive loss | (10,688) | (2,419) | |
Total stockholders' equity | 1,405,008 | 2,212,424 | |
Total liabilities and stockholders' equity |
Condensed Consolidated Statements of Cash Flows | |||
(In thousands) | |||
(Unaudited) | |||
Year Ended | |||
|
| ||
Operating Activities | |||
Net income | $ 91,402 | ||
Adjustments to reconcile net income to net cash provided by (used in) operating activities of continuing operations: | |||
Income from discontinued operations, net of income taxes | -- | (2,175,273) | |
Depreciation of property and equipment | 22,524 | 18,051 | |
Amortization of other intangible assets | 34,071 | 44,505 | |
Amortization of debt discount and debt issuance costs | 2,003 | 22,767 | |
Loss on extinguishment of convertible debt | 3 | 3,370 | |
Stock-based compensation expense | 60,510 | 56,842 | |
Equity-method earnings | (3,400) | (13,728) | |
Deferred income taxes | (18,240) | (3,414) | |
Changes in operating assets and liabilities: | |||
Accounts receivable | 26,876 | (3,144) | |
Inventories | (51,044) | (1,510) | |
Prepaid expenses and other assets | (31,240) | 44,664 | |
Accounts payable | 36,797 | (7,704) | |
Other current liabilities and income taxes | (12,738) | 2,109 | |
Deferred revenue and returns liability | (7,069) | 863 | |
Other non-current liabilities | (9,181) | (14,599) | |
Net cash provided by operating activities of continuing operations | 141,274 | 91,198 | |
Investing Activities | |||
Purchases of marketable securities | (607,237) | (1,541,971) | |
Sales of marketable securities | 223,354 | 250,075 | |
Maturities of marketable securities | 650,946 | 844,966 | |
Purchases of property and equipment | (26,525) | (28,577) | |
Purchases of other assets | -- | (1,158) | |
Net cash provided by (used in) investing activities of continuing operations | 240,538 | (476,665) | |
Financing Activities | |||
Payments on debt | (21) | (140,572) | |
Repurchases of common stock | (883,424) | (1,150,044) | |
Payment of taxes withheld for vested stock awards | (15,387) | (22,239) | |
Proceeds from the issuance of common stock | 11,779 | 14,183 | |
Net cash used in financing activities of continuing operations | (887,053) | (1,298,672) | |
Discontinued Operations | |||
Operating activities | (69,467) | (191,642) | |
Investing activities | -- | 2,747,684 | |
Net cash provided by (used in) discontinued operations | (69,467) | 2,556,042 | |
Increase (decrease) in cash and cash equivalents | (574,708) | 871,903 | |
Cash and cash equivalents at beginning of period | 1,074,623 | 202,720 | |
Cash and cash equivalents at end of period | $ 499,915 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/silicon-labs-reports-fourth-quarter-and-full-year-2022-results-301735610.html
SOURCE
FAQ
What were Silicon Labs' Q4 2022 revenue figures?
How much did Silicon Labs' revenue grow in the past two years?
What is the forecasted revenue for Silicon Labs in Q1 2023?
What was the gross margin for Silicon Labs in Q4 2022?